Antidepressants in Parkinson's disease. Recommendations by the movement disorder study group of the Neurological Association of Madrid
Authors:
- E. PeñaEPE. Peña
- M. MataMMM. Mata
- L. López-ManzanaresLLL. López-Manzanares
- M. KurtisMKM. Kurtis
- M. EimilMEM. Eimil
- J.C. Martínez-CastrilloJMJ.C. Martínez-Castrillo
- I. NavasINI. Navas
- I.J. PosadaIPI.J. Posada
- C. PrietoCPC. Prieto
- C. Ruíz-HueteCRC. Ruíz-Huete
- L. VelaLVL. Vela
- B. VenegasBVB. Venegas
Open Access
- 1 July 2018
- journal article
- Published by Elsevier in Neurología (English Edition)
- Vol. 33 (6) , 395-402
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Anxiety and Depression in Parkinson’s DiseaseCurrent Treatment Options in Neurology, 2014
- A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson’s DiseasePLOS ONE, 2013
- A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseNeurology, 2012
- Depression in Parkinson disease—epidemiology, mechanisms and managementNature Reviews Neurology, 2011
- A controlled trial of antidepressants in patients with Parkinson disease and depressionNeurology, 2009
- Levels of evidenceNeurology, 2009
- Invited Article: Practice parameters and technology assessmentsNeurology, 2008
- Invited Article: Lost in a jungle of evidenceNeurology, 2008
- Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled studyMovement Disorders, 2008
- Depression in idiopathic Parkinson's disease treated with citalopram: A placebo-controlled trialNordic Journal of Psychiatry, 1998